Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Intervalo de año de publicación
1.
Nutrients ; 12(3)2020 Mar 24.
Artículo en Inglés | MEDLINE | ID: mdl-32214021

RESUMEN

Retinal pigment epithelial cells are crucial for retina maintenance, making their cytoprotection an excellent way to prevent or slow down retinal degeneration. In addition, oxidative stress, inflammation, apoptosis, neovascularization, and/or autophagy are key pathways involved in degenerative mechanisms. Therefore, here we studied the effects of curcumin, lutein, and/or resveratrol on human retinal pigment epithelial cells (ARPE-19). Cells were incubated with individual or combined agent(s) before induction of (a) H2O2-induced oxidative stress, (b) staurosporin-induced apoptosis, (c) CoCl2-induced hypoxia, or (d) a LED-autophagy perturbator. Metabolic activity, cellular survival, caspase 3/7 activity (casp3/7), cell morphology, VEGF levels, and autophagy process were assessed. H2O2 provoked a reduction in cell survival, whereas curcumin reduced metabolic activity which was not associated with cell death. Cell death induced by H2O2 was significantly reduced after pre-treatment with curcumin and lutein, but not resveratrol. Staurosporin increased caspase-3/7 activity (689%) and decreased cell survival by 32%. Curcumin or lutein protected cells from death induced by staurosporin. Curcumin, lutein, and resveratrol were ineffective on the increase of caspase 3/7 induced by staurosporin. Pre-treatment with curcumin or lutein prevented LED-induced blockage of autophagy flux. Basal-VEGF release was significantly reduced by lutein. Therefore, lutein and curcumin showed beneficial protective effects on human-derived retinal cells against several insults.


Asunto(s)
Productos Biológicos/farmacología , Extractos Vegetales/química , Sustancias Protectoras/farmacología , Retina/citología , Retina/efectos de los fármacos , Verduras/química , Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Productos Biológicos/química , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Citoprotección/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Humanos , Estrés Oxidativo/efectos de los fármacos , Sustancias Protectoras/química , Especies Reactivas de Oxígeno/metabolismo , Epitelio Pigmentado de la Retina/citología , Epitelio Pigmentado de la Retina/efectos de los fármacos
2.
Neoplasia ; 19(1): 17-27, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27987437

RESUMEN

PURPOSE: This work reports, in melanoma models, the theranostic potential of ICF15002 as a single fluorinated and iodinated melanin-targeting compound. METHODS: Studies were conducted in the murine syngeneic B16BL6 model and in the A375 and SK-MEL-3 human xenografts. ICF15002 was radiolabeled with fluorine-18 for positron emission tomography (PET) imaging and biodistribution, with iodine-125 for metabolism study, and iodine-131 for targeted radionuclide therapy (TRT). TRT efficacy was assessed by tumor volume measurement, with mechanistics and dosimetry parameters being determined in the B16BL6 model. Intracellular localization of ICF15002 was characterized by secondary ion mass spectrometry (SIMS). RESULTS: PET imaging with [18F]ICF15002 evidenced tumoral uptake of 14.33±2.11%ID/g and 4.87±0.93%ID/g in pigmented B16BL6 and SK-MEL-3 models, respectively, at 1 hour post inoculation. No accumulation was observed in the unpigmented A375 melanoma. SIMS demonstrated colocalization of ICF15002 signal with melanin polymers in melanosomes of the B16BL6 tumors. TRT with two doses of 20 MBq [131I]ICF15002 delivered an absorbed dose of 102.3 Gy to B16BL6 tumors, leading to a significant tumor growth inhibition [doubling time (DT) of 2.9±0.5 days in treated vs 1.8±0.3 in controls] and a prolonged median survival (27 days vs 21 in controls). P53S15 phosphorylation and P21 induction were associated with a G2/M blockage, suggesting mitotic catastrophe. In the human SK-MEL-3 model, three doses of 25 MBq led also to a DT increase (26.5±7.8 days vs 11.0±3.8 in controls) and improved median survival (111 days vs 74 in controls). CONCLUSION: Results demonstrate that ICF15002 fulfills suitable properties for bimodal imaging/TRT management of patients with pigmented melanoma.


Asunto(s)
Radioisótopos de Yodo , Melanoma/diagnóstico por imagen , Melanoma/patología , Imagen Multimodal , Radiofármacos , Nanomedicina Teranóstica/métodos , Animales , Línea Celular Tumoral , Femenino , Humanos , Radioisótopos de Yodo/química , Radioisótopos de Yodo/metabolismo , Masculino , Melanoma/mortalidad , Melanoma/terapia , Melanoma Experimental , Ratones , Metástasis de la Neoplasia , Tomografía de Emisión de Positrones , Radioquímica , Radiofármacos/química , Radiofármacos/metabolismo , Distribución Tisular , Proteína Tumoral Controlada Traslacionalmente 1 , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Oncotarget ; 7(11): 12927-36, 2016 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-26887045

RESUMEN

Radiolabelled melanin ligands offer an interesting strategy for the treatment of disseminated pigmented melanoma. One of these molecules, ICF01012 labelled with iodine 131, induced a significant slowing of melanoma growth. Here, we have explored the combination of [131I]ICF01012 with coDbait, a DNA repair inhibitor, to overcome melanoma radioresistance and increase targeted radionuclide therapy (TRT) efficacy. In human SK-Mel 3 melanoma xenograft, the addition of coDbait had a synergistic effect on tumor growth and median survival. The anti-tumor effect was additive in murine syngeneic B16Bl6 model whereas coDbait combination with [131I]ICF01012 did not increase TRT side effects in secondary pigmented tissues (e.g. hair follicles, eyes). Our results confirm that DNA lesions induced by TRT were not enhanced with coDbait association but, the presence of micronuclei and cell cycle blockade in tumor shows that coDbait acts by interrupting or delaying DNA repair. In this study, we demonstrate for the first time, the usefulness of DNA repair traps in the context of targeted radionuclide therapy.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Reparación del ADN/efectos de los fármacos , ADN/farmacología , Melanoma Experimental/tratamiento farmacológico , Animales , Sinergismo Farmacológico , Femenino , Humanos , Radioisótopos de Yodo/farmacología , Masculino , Melanoma/patología , Melanoma Experimental/patología , Ratones , Ratones Endogámicos C57BL , Ratones Desnudos , Quinoxalinas/farmacología , Proteína Tumoral Controlada Traslacionalmente 1 , Ensayos Antitumor por Modelo de Xenoinjerto
4.
PLoS One ; 10(6): e0128395, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26042773

RESUMEN

In the present study, we have evaluated one of the dietary supplements enriched with antioxidants and fish oil used in clinical care for patient with age-related macular degeneration. Rats were orally fed by a gastric canula daily with 0.2 ml of water or dietary supplement until they were sacrificed. After one week of treatment, animals were either sacrificed for lipid analysis in plasma and retina, or used for evaluation of rod-response recovery by electroretinography (ERG) followed by their sacrifice to measure rhodopsin content, or used for progressive light-induced retinal degeneration (PLIRD). For PLIRD, animals were transferred to bright cyclic light for one week. Retinal damage was quantified by ERG, histology and detection of apoptotic nuclei. Animals kept in dim-cyclic-light were processed in parallel. PLIRD induced a thinning of the outer nuclear layer and a reduction of the b-wave amplitude of the ERG in the water group. Retinal structure and function were preserved in supplemented animals. Supplement induced a significant increase in omega-3 fatty acids in plasma by 168% for eicosapentaenoic acid (EPA), 142% for docosapentaenoic acid (DPA) and 19% for docosahexaenoic acid (DHA) and a decrease in the omega-6 fatty acids, DPA by 28%. In the retina, supplement induced significant reduction of linolenic acid by 67% and an increase in EPA and DPA by 80% and 72%, respectively, associated with significant decrease in omega-6 DPA by 42%. Supplement did not affect rhodopsin content or rod-response recovery. The present data indicate that supplement rapidly modified the fatty acid content and induced an accumulation of EPA in the retina without affecting rhodopsin content or recovery. In addition, it protected the retina from oxidative stress induced by light. Therefore, this supplement might be beneficial to slow down progression of certain retinal degeneration.


Asunto(s)
Antioxidantes/uso terapéutico , Suplementos Dietéticos , Progresión de la Enfermedad , Ácidos Grasos Omega-3/uso terapéutico , Luz/efectos adversos , Degeneración Retiniana/patología , Degeneración Retiniana/prevención & control , Animales , Apoptosis/efectos de la radiación , Vías Biosintéticas/efectos de la radiación , Electrorretinografía , Ácidos Grasos Omega-3/sangre , Ácidos Grasos Omega-6/sangre , Femenino , Masculino , Fármacos Neuroprotectores/uso terapéutico , Plasmalógenos/metabolismo , Ratas Sprague-Dawley , Regeneración/efectos de la radiación , Retina/patología , Retina/efectos de la radiación , Degeneración Retiniana/sangre , Células Fotorreceptoras Retinianas Bastones/patología , Células Fotorreceptoras Retinianas Bastones/efectos de la radiación , Rodopsina/metabolismo
5.
Invest Ophthalmol Vis Sci ; 52(3): 1261-74, 2011 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-20881284

RESUMEN

PURPOSE: Retinal degeneration is associated with iron accumulation in several rodent models in which iron-regulating proteins are impaired. Oxidative stress is catalyzed by unbound iron. METHODS: The role of the heavy chain of ferritin, which sequesters iron, in regulating the thickness of the photoreceptor nuclear layer in the 4- and 16-month-old wild-type H ferritin (HFt(+/+)) and heterozygous H ferritin (HFt(+/-)) mice was investigated, before and 12 days after exposure to 13,000-lux light for 24 hours. The regulation of gene expression of the various proteins involved in iron homeostasis, such as transferrin, transferrin receptor, hephaestin, ferroportin, iron regulatory proteins 1 and 2, hepcidin, ceruloplasmin, and heme-oxygenase 1, was analyzed by quantitative (q)RT-PCR during exposure (2, 12, and 24 hours) and 24 hours after 1 day of exposure in the 4-month-old HFt(+/+) and HFt(+/-) mouse retinas. RESULTS: Retinal degeneration in the 4-month-old HFt(+/-) mice was more extensive than in the HFt(+/+) mice. Yet, it was more extensive in both of the 16-month-old mouse groups, revealing the combined effect of age and excessive light. Injury caused by excessive light modified the temporal gene expression of iron-regulating proteins similarly in the HFt(+/-) and HFt(+/+) mice. CONCLUSIONS: Loss of one allele of H ferritin appears to increase light-induced degeneration. This study highlighted that oxidative stress related to light-induced injury is associated with major changes in gene expression of iron metabolism proteins.


Asunto(s)
Envejecimiento/fisiología , Apoferritinas/genética , Regulación de la Expresión Génica/fisiología , Proteínas de Unión a Hierro/genética , Traumatismos Experimentales por Radiación/genética , Retina/efectos de la radiación , Degeneración Retiniana/genética , Animales , Apoferritinas/metabolismo , Proteínas de Transporte de Catión/genética , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Hierro/metabolismo , Luz , Masculino , Ratones , Ratones Endogámicos BALB C , Estrés Oxidativo , ARN Mensajero/genética , Traumatismos Experimentales por Radiación/etiología , Traumatismos Experimentales por Radiación/metabolismo , Degeneración Retiniana/etiología , Degeneración Retiniana/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
6.
Bioorg Med Chem Lett ; 20(24): 7405-9, 2010 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-21071218

RESUMEN

Two cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives were synthesized as antioxidants against light-induced retinal degeneration. Whereas nitrone 10 significantly protected retina against bright fluorescent light exposure when injected into the vitreous at 1 mM, no protection was observed with nitrone 6. The parent compound α-phenyl-N-tert-butyl nitrone also exhibited protective activity at 9 mM but not at 1 mM. This suggests that nitrone 10 may be a candidate for the treatment of retinal diseases.


Asunto(s)
Antioxidantes/química , Colesterol/análogos & derivados , Colesterol/química , Óxidos N-Cíclicos/química , Disacáridos/química , Iminas/química , Luz , Degeneración Retiniana/prevención & control , Animales , Antioxidantes/síntesis química , Antioxidantes/uso terapéutico , Colesterol/síntesis química , Colesterol/uso terapéutico , Óxidos N-Cíclicos/síntesis química , Óxidos N-Cíclicos/uso terapéutico , Disacáridos/síntesis química , Disacáridos/uso terapéutico , Iminas/síntesis química , Iminas/uso terapéutico , Ratas , Especies Reactivas de Oxígeno/metabolismo , Enfermedades de la Retina/tratamiento farmacológico
7.
Exp Eye Res ; 85(6): 782-9, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17961554

RESUMEN

Erythropoietin (Epo) had been shown to have a neuroprotective effect independent from its erythropoietic properties. In this study, we tested whether Epo could protect the retina from damage induced by a long period of moderate light insult and how it protected. First, rats were injected intraperitoneally (i.p.) by human recombinant Epo at 5000 or 30,000U/kg to assess Epo concentration in plasma and retina. Second, rats were untreated or injected i.p. with Epo at 30,000U/kg, 1 or 4h before being placed in constant light (24h; 2200lux). Electroretinograms (ERG) were recorded before treatment, 1day and 15days (D15) after light exposure. After the last ERG, eyes were taken for histology. In parallel, we tested Epo protection against oxidative stressors on isolated retinas and its effect on caspase-9 activity. Epo injected at 30,000U/kg body weight, 4h before exposure to the damaging light, protected retinal function and structure against light damage and induced an increase in caspase-9 activity and expression. Epo had no direct or indirect protective effect against free radicals-induced death on isolated retinas. Epo protected the retina from a long period of moderate light exposure through a mechanism independent from a free radical scavenging property or an antioxidant facilitating activity. The activation of caspase-9, 4h after Epo injection, corresponding to the start of light exposure, suggests that caspase-9 plays a role in neuroprotection.


Asunto(s)
Caspasa 9/metabolismo , Eritropoyetina/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Traumatismos por Radiación/prevención & control , Degeneración Retiniana/prevención & control , Animales , Evaluación Preclínica de Medicamentos , Electrorretinografía , Activación Enzimática/efectos de los fármacos , Eritropoyetina/farmacocinética , Radicales Libres/metabolismo , Luz/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Traumatismos por Radiación/metabolismo , Ratas , Ratas Wistar , Proteínas Recombinantes , Retina/metabolismo , Retina/fisiología , Degeneración Retiniana/etiología , Degeneración Retiniana/metabolismo , Técnicas de Cultivo de Tejidos
8.
Invest Ophthalmol Vis Sci ; 48(6): 2753-9, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17525209

RESUMEN

PURPOSE: To study the apoptotic mechanism involved in our model of light-induced retinal degeneration. METHODS: Rats were injected intravitreally with PBS, 2% dimethyl sulfoxide (DMSO), caspase inhibitor Z-VAD-FMK (1.06 mM), Z-YVAD-FMK (0.16 mM), or Z-DEVD-FMK (2 mM) before they were placed in constant light (3400 lux) for 24 hours. Additional controls included rats that were uninjected or were punctured with a dry needle. Electroretinograms were recorded before injection and 1 day after the cessation of exposure to constant light. A group of rats was killed for apoptotic cell detection in the outer nuclear layer. Fifteen days later, the remaining rats were killed for histology, and the outer nuclear layer (ONL) thickness was measured. Caspase-1, caspase-3, and calpain activities were measured before and 1 day after exposure to the damaging light. RESULTS: ZVAD, YVAD, and DEVD inhibited caspase-1 and -3 activities, but not calpain activity, from the beginning and up to 1 day after light exposure. In untreated, dry needle-punctured, PBS, DMSO, and YVAD groups, light exposure significantly reduced retinal function and ONL thickness and increased by 51-fold the number of apoptotic cells. ZVAD and DEVD preserved retinal function to 86% and 78%, respectively, and reduced by three times the number of apoptotic photoreceptors. ONL thickness was more preserved in ZVAD (to 72%) than in DEVD (to 56%). CONCLUSIONS: In the authors' model of retinal degeneration, photoreceptor cells die through a caspase-dependent mechanism. However, the molecular events involved during and after light exposure seemed to implicate different proteases.


Asunto(s)
Apoptosis , Caspasa 1/metabolismo , Caspasa 3/metabolismo , Luz/efectos adversos , Traumatismos Experimentales por Radiación/patología , Retina/efectos de la radiación , Degeneración Retiniana/patología , Animales , Calpaína/metabolismo , Inhibidores de Caspasas , Inhibidores de Cisteína Proteinasa/farmacología , Dimetilsulfóxido/farmacología , Electrorretinografía , Células Fotorreceptoras de Vertebrados/patología , Traumatismos Experimentales por Radiación/enzimología , Traumatismos Experimentales por Radiación/etiología , Ratas , Ratas Wistar , Retina/enzimología , Degeneración Retiniana/enzimología , Degeneración Retiniana/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA